Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer
Abstract Costimulatory molecules can promote the activation and proliferation of T cells and play an essential role in immunotherapy. However, their role in the prognosis of colon adenocarcinoma remains elusive. In this study, the expression data of costimulatory molecules and clinicopathological in...
Main Authors: | Wanze Huang, Duntao Su, Xin Liao, Tongtong Yang, Yan Lu, Zhejia Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-27826-7 |
Similar Items
-
Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
by: Shengdong Ge, et al.
Published: (2021-08-01) -
Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer
by: Yan Yang, et al.
Published: (2024-09-01) -
Identification of a costimulatory molecule-based signature to predict prognostic risk of pancreatic adenocarcinoma
by: Chao Wu, et al.
Published: (2022-12-01) -
Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3
by: Qi Wang, et al.
Published: (2022-06-01) -
Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
by: Chaoqi Zhang, et al.
Published: (2020-01-01)